Showing results (1321-1330 of 1,708) with videos related to

Sort By:
Pageof 171
Journal of the American Heart Association|February 21, 2023
Cardiovascular Benefits of Icosapent Ethyl in Patients With and Without Atrial Fibrillation in REDUCE-ITBrian Olshansky, Deepak L Bhatt, Michael Miller, et al.
Annals of the Rheumatic Diseases|September 24, 2025
Use of statins and its association with major adverse cardiovascular events with tofacitinib vs TNF inhibitors in patients with rheumatoid arthritis with and without atherosclerotic cardiovascular diseaseJon T Giles, Christina Charles-Schoeman, Maya H Buch, et al.
JAMA Neurology|October 28, 2024
Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous ThrombolysisBrian Mac Grory, Jie-Lena Sun, Brooke Alhanti, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2021
A randomized trial comparing axillary versus innominate artery cannulation for aortic arch surgeryMark D Peterson, Vinay Garg, C David Mazer, et al.
The New England Journal of Medicine|June 25, 2023
Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASHRohit Loomba, Arun J Sanyal, Kris V Kowdley, et al.
European Heart Journal|December 18, 2021
Alirocumab after acute coronary syndrome in patients with a history of heart failureHarvey D White, Gregory G Schwartz, Michael Szarek, et al.
Circulation|February 22, 2019
Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes MellitusThomas A Zelniker, Stephen D Wiviott, Itamar Raz, et al.
Lancet (London, England)|September 3, 2025
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysisMarco Valgimigli, Ki Hong Choi, Daniele Giacoppo, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
American Heart Journal|January 31, 2021
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)Andrew P Ambrosy, Umar I Malik, Rachel C Thomas, et al.
Pageof 171